We are live on ! Find out more
GP

GSK plc Portfolio holdings

AUM $602M
This Fund
S&P 500
This Quarter Est. Return
-12.19%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$599M
AUM Growth
-$200M
Cap. Flow
-$67.4K
Cap. Flow %
-0.01%
Top 10 Hldgs %
97.33%
Holding
15
New
–
Increased
–
Reduced
–
Closed
2
Avg Time Held
1 quarter
Top 10 Avg Time Held
0.9 quarters
Top 20 Avg Time Held
1 quarter

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SENS icon
Senseonics Holdings Inc
SENS
+$59.9K
2
HBIO icon
Harvard Bioscience
HBIO
+$7.46K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.99B
$153M 25.57%
3,220,627
– –
2025 Q4
1 quarter
WVE icon
2
Wave Life Sciences
WVE
$648M
$132M 22.08%
18,245,691
– –
2025 Q4
1 quarter
BNTX icon
3
BioNTech
BNTX
$24.1B
$79.1M 13.2%
889,824
– –
2025 Q4
1 quarter
VIR icon
4
Vir Biotechnology
VIR
$1.9B
$76.6M 12.79%
8,550,954
– –
2025 Q4
1 quarter
IDYA icon
5
IDEAYA Biosciences
IDYA
$3.47B
$44.4M 7.41%
1,333,333
– –
2025 Q4
1 quarter
LYEL icon
6
Lyell Immunopharma
LYEL
$205M
$30.3M 5.06%
1,512,659
– –
2025 Q4
1 quarter
CYTK icon
7
Cytokinetics
CYTK
$8.77B
$22.4M 3.75%
340,434
– –
2025 Q4
1 quarter
SPRO icon
8
Spero Therapeutics
SPRO
$69.3M
$21.5M 3.59%
9,190,606
– –
2025 Q4
1 quarter
FULC icon
9
Fulcrum Therapeutics
FULC
$286M
$13.7M 2.29%
1,785,714
– –
2025 Q4
1 quarter
CVRX icon
10
CVRx
CVRX
$40.2M
$9.53M 1.59%
1,007,583
– –
2025 Q4
1 quarter
BCYC icon
11
Bicycle Therapeutics
BCYC
$266M
$7.1M 1.18%
1,529,561
– –
2025 Q4
1 quarter
NKTX icon
12
Nkarta
NKTX
$157M
$6.65M 1.11%
3,150,732
– –
2025 Q4
1 quarter
RGNX icon
13
Regenxbio
RGNX
$518M
$2.27M 0.38%
271,456
– –
2025 Q4
1 quarter
HBIO icon
14
Harvard Bioscience
HBIO
$38.2M
– –
-1,115
Closed -$7.46K –
SENS icon
15
Senseonics Holdings Inc
SENS
$490M
– –
-10,856
Closed -$59.9K –

Similar funds

FIC
Family Investment Center Saint Joseph, Missouri $602M AUM 19.6% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $602M AUM 37.09% 1-Year Est. Return
PWP
Precedent Wealth Partners Houston, Texas $601M AUM 23.36% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $603M AUM 62.42% 1-Year Est. Return
OPWM
Oakwell Private Wealth Management Austin, Texas $603M AUM 24.07% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
PCTC
Perkins Coie Trust Company Seattle, Washington $603M AUM 23.96% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

GSK plc's Q1 2026 Portfolio in Review

As of Q1 2026, GSK plc held 15 positions worth $599M, down 25% from $799M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

GSK plc's Q1 2026 filing shows 2 closed positions. The largest sale was Senseonics Holdings Inc, an estimated $59.9K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • GSK plc fully exited Senseonics Holdings Inc in Q1 2026, selling an estimated $59.9K.
  • GSK plc's ten largest holdings make up 97% of its $599M portfolio in Q1 2026.
  • GSK plc opened 0 new positions and closed 2 in Q1 2026.
  • GSK plc's portfolio value fell 25% quarter-over-quarter to $599M.

Based on GSK plc's 13F filing for Q1 2026, filed 14 May 2026.